Discovery of LHRH and development of LHRH analogs for prostate cancer treatment

Andrew V Schally, Norman L Block, Ferenc G. Rick

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

The discovery, isolation, elucidation of structure, synthesis, and initial testing of the neuropeptide hypothalamic luteinizing hormone-releasing hormone (LHRH), which regulates reproduction, is briefly described. The design, synthesis, and experimental and clinical testing of agonistic analogs of LHRH is extensively reviewed focusing on the development of new methods for the treatment of prostate cancer. Subsequent development of antagonistic analogs of LHRH is then faithfully recounted with special emphasis on therapy of prostate cancer and BPH. The concepts of targeted therapy to peptide receptors on tumors are re-examined and the development of the cytotoxic analogs of LHRH and their status is reviewed. The endeavor to develop better therapies for prostate cancer, based on LHRH analogs, guided much of our work.

Original languageEnglish (US)
Pages (from-to)1036-1054
Number of pages19
JournalProstate
Volume77
Issue number9
DOIs
StatePublished - Jun 15 2017

Fingerprint

Gonadotropin-Releasing Hormone
Prostatic Neoplasms
Hypothalamic Hormones
Peptide Receptors
Neuropeptides
Reproduction
Research Design
Therapeutics
Neoplasms

Keywords

  • advanced prostate cancer
  • androgen deprivation therapy
  • CRPC
  • luteinizing hormone-releasing hormone
  • targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment. / Schally, Andrew V; Block, Norman L; Rick, Ferenc G.

In: Prostate, Vol. 77, No. 9, 15.06.2017, p. 1036-1054.

Research output: Contribution to journalReview article

Schally, Andrew V ; Block, Norman L ; Rick, Ferenc G. / Discovery of LHRH and development of LHRH analogs for prostate cancer treatment. In: Prostate. 2017 ; Vol. 77, No. 9. pp. 1036-1054.
@article{c0b2fa6aacef48bf8d7d16544512918f,
title = "Discovery of LHRH and development of LHRH analogs for prostate cancer treatment",
abstract = "The discovery, isolation, elucidation of structure, synthesis, and initial testing of the neuropeptide hypothalamic luteinizing hormone-releasing hormone (LHRH), which regulates reproduction, is briefly described. The design, synthesis, and experimental and clinical testing of agonistic analogs of LHRH is extensively reviewed focusing on the development of new methods for the treatment of prostate cancer. Subsequent development of antagonistic analogs of LHRH is then faithfully recounted with special emphasis on therapy of prostate cancer and BPH. The concepts of targeted therapy to peptide receptors on tumors are re-examined and the development of the cytotoxic analogs of LHRH and their status is reviewed. The endeavor to develop better therapies for prostate cancer, based on LHRH analogs, guided much of our work.",
keywords = "advanced prostate cancer, androgen deprivation therapy, CRPC, luteinizing hormone-releasing hormone, targeted therapy",
author = "Schally, {Andrew V} and Block, {Norman L} and Rick, {Ferenc G.}",
year = "2017",
month = "6",
day = "15",
doi = "10.1002/pros.23360",
language = "English (US)",
volume = "77",
pages = "1036--1054",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Discovery of LHRH and development of LHRH analogs for prostate cancer treatment

AU - Schally, Andrew V

AU - Block, Norman L

AU - Rick, Ferenc G.

PY - 2017/6/15

Y1 - 2017/6/15

N2 - The discovery, isolation, elucidation of structure, synthesis, and initial testing of the neuropeptide hypothalamic luteinizing hormone-releasing hormone (LHRH), which regulates reproduction, is briefly described. The design, synthesis, and experimental and clinical testing of agonistic analogs of LHRH is extensively reviewed focusing on the development of new methods for the treatment of prostate cancer. Subsequent development of antagonistic analogs of LHRH is then faithfully recounted with special emphasis on therapy of prostate cancer and BPH. The concepts of targeted therapy to peptide receptors on tumors are re-examined and the development of the cytotoxic analogs of LHRH and their status is reviewed. The endeavor to develop better therapies for prostate cancer, based on LHRH analogs, guided much of our work.

AB - The discovery, isolation, elucidation of structure, synthesis, and initial testing of the neuropeptide hypothalamic luteinizing hormone-releasing hormone (LHRH), which regulates reproduction, is briefly described. The design, synthesis, and experimental and clinical testing of agonistic analogs of LHRH is extensively reviewed focusing on the development of new methods for the treatment of prostate cancer. Subsequent development of antagonistic analogs of LHRH is then faithfully recounted with special emphasis on therapy of prostate cancer and BPH. The concepts of targeted therapy to peptide receptors on tumors are re-examined and the development of the cytotoxic analogs of LHRH and their status is reviewed. The endeavor to develop better therapies for prostate cancer, based on LHRH analogs, guided much of our work.

KW - advanced prostate cancer

KW - androgen deprivation therapy

KW - CRPC

KW - luteinizing hormone-releasing hormone

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85019234492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019234492&partnerID=8YFLogxK

U2 - 10.1002/pros.23360

DO - 10.1002/pros.23360

M3 - Review article

VL - 77

SP - 1036

EP - 1054

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 9

ER -